Exercise slows tumor growth in mice by shifting glucose uptake to muscles

It’s well known that exercise is good for health and helps to prevent serious diseases, like cancer and heart disease, along with simply making people feel better overall. However, the molecular mechanisms responsible for preventing cancer or slowing its progression are not well understood. But, a new study, published in the Proceedings of the National Academy of Sciences, reveals how exercise can increase glucose and oxygen uptake in the skeletal and cardiac muscles, instead of allowing it to “feed” tumors.

Reduced tumor growth in exercised mice

To study how exercise-induced metabolic changes affect tumor growth, the research team injected mice with breast cancer cells and fed some of the mice a high-fat diet (HFD), consisting of 60% calories from fat, while others were fed a normal diet as a control. The HFD mice were given running wheels for exercise, although exercise was voluntary. The team used stable isotope tracer studies [U-13C6] glucose and [U-13C5] glutamine to track metabolic changes.

After 4 weeks of wheel running, the team found a significant difference in tumor sizes between mice that chose to exercise, compared to those that did not—even when they were fed the same diet.

The study authors write, “Obese mice which underwent 4 weeks of voluntary wheel running after tumor injection exhibited nearly a 60% reduction in tumor size. The exercised mice had greater lean mass and lower fat mass than their nonexercised, obese counterparts, with plasma glucose and insulin concentrations comparable to the sedentary chow fed controls.

“After a 30-min bout of acute moderate intensity (15 m/min) treadmill exercise, the exercised obese mice had higher cardiac and skeletal muscle 2-deoxyglucose uptake and reduced tumor glucose uptake.”

The researchers also analyzed exercise-induced changes in mice with a type of melanoma that is typically not exacerbated by obesity (in contrast to breast cancer). Still, after four weeks of exercise, obese mice with melanoma had significantly smaller tumor sizes, along with reductions in tumor glucose uptake and oxidation compared to the sedentary controls. These results suggest that the shift in glucose (and thus the slowing of tumor growth) is not tumor-type specific.

Some mice also underwent “prehabilitation”—exercise undertaken before tumors were introduced. Similar beneficial results were found in these mice. The study authors explain, “These observations may be due to an earlier achievement and maintenance of body composition or overall fitness (VO2 peak) with early exercise exposure.”

Exercise-induced metabolic changes

The repartitioning of glucose to cardiac and skeletal muscles instead of tumors appears to play a major role in slowing tumor growth, but there are other changes taking place, as well. The team also found 417 genes related to energy metabolism and other metabolic pathways that were expressed differently between exercised and sedentary lean mice.

The team says that a downregulation in a protein referred to as mTOR, is seen in the exercised mice and this may be helping to slow tumor growth, along with processes like shifts in the use of amino acids, which tumors have been documented to utilize.

Does exercise slow tumor growth in humans?

The team also gathered gene expression data from another study, which analyzed exercise training in women with breast cancer and a metaanalysis of skeletal muscle responses to multiple types of acute and chronic exercise. The data revealed an upregulation in the glutamine and leucine channeling genes in the muscle tissue of humans who exercise. They say that no distinct differences were observed in the expression pattern of these genes when comparing exercise intensity, which may be due to the small sample size or the limited number of analyzed genes.

So, more research is certainly required, but since metabolic pathways are similar in humans, mice, and other mammals, there is likely a similar relationship between exercise and tumor growth in humans. This would be in line with other studies indicating tumor suppression with the help of exercise in humans.

Overall, researchers remain optimistic about exercise in the role of cancer treatment in humans. A better understanding of how glucose is utilized after exercise in humans with tumors can inform prehabilitation strategies for cancer patients, help doctors integrate fitness into cancer therapies, and potentially assist researchers in identifying new therapeutic targets.

“We anticipate that this work may lay the groundwork to reveal key insights into the role of systemic adaptations to exercise in broader antitumor therapies. Further, examination of the role of fitness on the molecular pathways altered by exercise may uncover new therapeutic targets in precision oncology, particularly in patients who cannot tolerate exercise,” the study authors explain.

Childhood instability accelerates women’s sexual strategies, study suggests

California State University, Sacramento, researchers traced how disordered childhood social worlds in women connected to faster life history traits and greater mating effort, with those traits explaining 22.2% of the association between childhood microsystems and adult sexual behavior.

Childhood environments and strategies

Life History theory treats childhood ecology as a starting point for strategies that govern survival, mating effort, and parental effort. Mating effort involves behavior that increases access to sexual opportunities, while parental effort involves investing time and resources so children survive to reproduce.

Faster strategies align with earlier sexual debut, more short-term mating, more lifetime partners, and more offspring at younger ages. Slower strategies align with later sexual debut, safer reproductive behavior such as monogamy and contraceptive use, fewer lifetime partners, and greater parental investment.

Childhood harshness and unpredictability show up in prior work through divorce, parental job loss, frequent moves, unsafe neighborhoods, and parental substance misuse or violence. Supportive and predictable childhood environments appear with nurturing parents, stable housing, and safer neighborhoods.

Bioecological theory describes environmental layers that interact with the child over time. Microsystems contain parents, extended family, teachers, and neighbors who interact frequently and reciprocally with the child. Exosystems include factors that affect the child indirectly, such as parental employment or frequent moves.

Prior studies linked parental disengagement, father absence, and neighborhood violence to short-term mating, early sexual debut, and sexually risky behavior in adolescence and adulthood. Harsh and unpredictable environments relate to present-oriented thinking and impulsivity, which then link to risky sexual behavior. Dark Triad traits, including psychopathy and Machiavellianism, support resource control, low self-control, and mating effort, along with sexually risky behavior.

Slower profiles are associated with traits such as long-term planning, agreeableness, conscientiousness, mental and physical health, well-being, self-esteem, positive affect, and emotional intelligence.

In the study, “Using SEM to test the associations among women’s childhood ecology, adult psychosocial life history traits, and mating effort,” published in Evolution and Human Behavior, researchers used structural equation modeling to investigate how childhood microsystem and exosystem experiences, adult psychosocial traits, and mating effort fit together in women.

Participants were 875 ethnically mixed, self-identified female undergraduate college students at a university in Northern California. Ages ranged from 18 to 46 years, with a mean age of 20.55. Questionnaires included childhood ecology, adult psychosocial traits, and mating effort along with Adverse Childhood Experiences (ACE) Inventory, a 20-item checklist of hardships in childhood.

Childhood trauma, control, and partners

Correlations between microsystem indicators, faster traits, and mating effort unpacked those paths. Higher microsystem scores related to higher ACE scores, paternal and maternal disengagement, more parental cohabitation, and higher neighborhood crime. Higher microsystem scores also related to higher, faster scores and Dark Triad psychopathy, higher coercive and power-seeking resource control, higher Machiavellianism, and lower self-control.

Psychopathy showed strong links to mating effort. Higher psychopathy correlated with more lifetime sexual partners, stronger short-term mating orientation, and greater future sexual risk intentions. Machiavellianism correlated with stronger short-term mating orientation and greater future sexual risk intentions.

Self-control scores related inversely to harsh childhood conditions. Higher ACE scores and more neighborhood crime correlated with lower self-control. Lower self-control correlated with more lifetime sexual partners, more openness to casual sex, and higher future sexual risk intentions.

Resource control strategies formed another bridge. Neighborhood crime correlated with higher coercive and power-seeking resource control. Higher coercive and power-seeking scores correlated with more partners, stronger short-term mating orientation, and higher future risk intentions.

Higher neuroticism correlated with higher ACE scores, more neighborhood crime, higher father disengagement, stronger short-term mating orientation, and greater future sexual risk intentions.

Sexual start patterns

Age at first sexual encounter could not be included in the structural equation model because a substantial number of participants reported no sexual experience. 284 women reported never having sex, leaving 591 with a reported age at sexual debut. A hierarchical multiple regression used microsystem, exosystem, slower traits, and faster traits as predictors of age at sexual debut in that subgroup.

Women who grew up in more chaotic or troubled family and neighborhood environments tended to start having sex at younger ages. Broader issues such as money instability and slower life history traits did not change that pattern much.

Women with higher adversity scores, more disengaged fathers, more non-relatives living in the home, higher psychopathy, a stronger drive to control others and resources, and higher neuroticism reported younger ages at first sex.

Mothers

A total of 33 participants reported having children. For this analysis, 37 participants without children were randomly sampled to form a comparison group of 70 women.

Microsystem and exosystem scores did not significantly predict having children. Slower and faster traits did. Women in this small subgroup who showed more of the slower life history traits (things like resilience, well-being, conscientiousness, secure attachment, and grit) were more likely to have children than women with lower scores on those traits.

Women in this small subgroup who had children differed from those without children mainly in their adult traits, not in their reported childhood environments. Mothers tended to score lower on fast life history traits such as psychopathy, low self-control, and power-seeking, and higher on slow traits, while the childhood microsystem and exosystem scores did not clearly separate mothers from non-mothers.

Life history patterns and implications

Psychosocial life history traits clustered into two partly independent sets, one faster and one slower. Faster traits were linked both to harsher childhood microsystems and to higher mating efforts, many of which are explicitly risky or short term. Slower traits were linked to kinder childhood microsystems, and showed statistically non-significant associations with mating effort.

Microsystem conditions before age 10 are linked more strongly to psychosocial traits and mating effort than exosystem conditions. Childhood trauma, parental disengagement, parental cohabitation with non-kin adults, and neighborhood crime all clustered within higher microsystem scores and connected to faster traits, more partners, shorter-term mating orientation, and higher future sexual risk intentions.

Perceived resource inconsistency in the exosystem added further associations with partner counts, short-term orientation, and risk intentions.

Conclusions, limitations and open questions

Results showed that the childhood microsystem had a far greater impact than the external environment on personality development and mating strategies. Good parenting and a protective early environment that allowed security and predictability showed a trajectory of positive associations.

The cohort included only college students, a major limitation for generalizing the findings, as college attendance is conceivably a measurable outcome of Life History theory. How the findings might compare to women who did not attend college, and how this socioeconomic cutoff might alter the strength of the associations is unclear.

Researchers develop sustainable technology to extract isoflavones from soybean meal

A study conducted at the State University of Campinas (UNICAMP) in the state of São Paulo, Brazil, has proven the efficiency of a sustainable process for extracting isoflavones from soybean meal that increases their bioavailability.

Isoflavones are used in foods, cosmetics, and supplements due to their health benefits, including combating neurodegenerative and cardiovascular diseases, type 1 and type 2 diabetes, hyperglycemia, and exhibiting anticancer, antimicrobial, and antioxidant activities. They also bind to estrogen receptors, modulating hormonal imbalances and potentially alleviating or preventing menopause-related symptoms.

The problem is that traditionally, these isoflavones are separated from the meal using time-consuming techniques involving toxic solvents.

“That’s why our research sought to solve this issue by applying innovative and sustainable technology that combines environmentally friendly solvents under high pressure with ultrasonic waves to intensify the extraction,” explains Pedro Henrique Santos, a food engineer from the Multidisciplinary Food and Health Laboratory (LabMAS) at the Faculty of Applied Sciences (FCA) at UNICAMP who participated in the study.

The results were published in Food Chemistry.

After discovering the most efficient way to extract isoflavones from soybean meal using the new technology, the researchers applied an enzyme that broke the isoflavones down into smaller molecules called genistein and daidzein. These molecules are more easily absorbed by the human body, similar to what happens with lactose-free milk.

“The combination of the two steps resulted in an extract that is completely rich in isoflavones already in their active form [genistein and daidzein], in less time than traditional methods and in a 100% sustainable manner. In addition, the meal left over from the process retained its high protein content and can be used in animal feed or in the development of vegetable protein supplements, generating two high-value-added products from the same by-product,” says Santos.

Cocoa bean shells

Some of the researchers who worked on this study dedicated themselves to finding a new way to add value to an interesting cocoa byproduct: the almond shells of the fruit. The shells resemble cocoa nibs and have a similar smell, but they are very fibrous, so they are usually discarded.

“The material has compounds that may be of interest to different industries, such as food and cosmetics, as it has beneficial health effects. Therefore, our intention was to extract these substances in order to obtain an enriched fraction in each of them,” says Felipe Sanchez Bragagnolo, a process and biotechnology engineer who works in the same laboratory as Santos.

The study was the subject of another article in Food Chemistry.

To accomplish this, the researchers, assisted by María González-Miquel from the Polytechnic University of Madrid in Spain and Dario Arrua from the Future Industries Institute at the University of South Australia, used equipment operating at pressures much higher than those of a domestic pressure cooker.

In this system, water and ethanol (safe solvents) pass through the shells of the cocoa beans and extract the desired compounds into the solution.

The solution then enters a smart filter that separates the compounds according to their chemical affinity. Those that “like” water more appear in the more aqueous fractions, while those that “prefer” ethanol appear in the fractions with more ethanol. This process allows for the production of purer portions of each group of compounds.

Using this method, the scientists improved the system, enabling them to extract and separate the compounds. They obtained a fraction rich in theobromine, the main compound in cocoa bean shells. Next, they obtained a fraction rich in caffeine, followed by a final fraction full of phenolic compounds.

“The findings can be used in different approaches. One of them is the use of the system for raw material quality control, as we were able to verify, in fewer steps, what’s in the plant material and how much of it there is. Another application, more specific to cocoa, is the targeted use of the fractions,” Bragagnolo explains.

This means that, for example, if an industry is interested in using theobromine in a product, it will be possible to scale up the process and obtain a purer, enriched fraction of theobromine from cocoa bean shells.

Technology boosts hop production in Brazil and paves way for new bioproducts

Despite being the third-largest producer and consumer of beer worldwide, Brazil depends almost entirely on hop imports. Less than 1% of the ingredient responsible for the bitterness, aroma, and flavor of beer is grown locally. However, a new project involving Brazilian scientists and producers in the Vale do Ribeira region of the state of São Paulo seeks to change this scenario. The project aims to make domestic hop production more efficient and viable while boosting the development of new bioproducts.

The project was born within the Center for Research on Biodiversity Dynamics and Climate Change (CBioClima), one of the Research, Innovation, and Dissemination Centers (RIDCs) and based at São Paulo State University (UNESP). The project is investing in supercritical extraction with carbon dioxide (CO₂), a technology that is already well-established in countries such as Germany and the United States. This method efficiently extracts aromatic and bioactive compounds from hops, reducing logistics costs and improving beer quality.

“Brazilian hops are normally sold in pellets [dehydrated and pressed flowers] to breweries. However, with this technology, hops can be marketed in oil form, which, in addition to logistical gains, yields beer production results that are far superior to conventional methods,” explains Levi Pompermayer Machado, a professor at UNESP and one of the researchers involved in the project.

In the study published in the journal Biomass Conversion and Biorefinery, the researchers compared the extraction of hops at Atlântica Hops in the municipality of Juquiá in Vale do Ribeira using conventional and supercritical CO₂ methods.

While traditional extraction, which uses organic solvents or a technique known as steam stripping, yields about 15% extract with 9% α-acids (the compounds responsible for the bitterness of beer), the CO₂ method achieves up to 72% α-acids. Additionally, the process results in a lower volume, better preservation, and an increase of up to 20% in beer productivity.

“Each hop has a unique flavor, which is defined by what we call terroir, and that’s what the industry is looking for. In the study, we also conducted analyses of the sensory profile of the hop extract in pellets and the extract we produced. There was a slight change in flavor, but the sensory signature of the product remained more or less the same. Therefore, with all this improvement in efficiency and quality, the characteristics of the terroir are almost entirely maintained,” he says.

Machado points out that the technology tested in Vale do Ribeira stands out for adhering to the principles of green chemistry. Traditional methods use large amounts of water or petroleum-based solvents to separate essential oils from hops.

Supercritical extraction, on the other hand, uses carbon dioxide under high-pressure, high-temperature conditions where it exists in a state between liquid and gas (the supercritical state). In this state, CO₂ acts as a natural solvent, penetrating deeply into the raw material and extracting its compounds with high efficiency.

“In addition, the CO₂ used in supercritical technology is recaptured at the end of the process, which avoids atmospheric emissions and eliminates chemical residues in the extract. This makes the method more efficient and environmentally responsible,” says Machado.

The researcher states that the main objective of the project is to provide producers with cultivation options that have a smaller environmental footprint and greater added value (as is the case with hops), rather than expanding agricultural frontiers with low-value commodities such as soybeans and sugarcane.

“We’re talking about producing more in a much smaller cultivated area, with a crop that responds well to climate change and offers multiple market possibilities,” the researcher points out.

Circular economy

Another advantage of this technology is that the resulting extracts can be used not only in the brewing industry but also in the cosmetics and pharmaceutical sectors. In addition to the extracts, the researchers analyzed the waste left over after extraction (spent hops).

Johana Marcela Concha Obando, a postdoctoral fellow at INCT NanoAgro at UNESP who is involved in the project, explains that hop waste still contains bioactive compounds with high antioxidant potential, such as phenolics and flavonoids.

“Since the technique doesn’t use reagents, this waste isn’t lost in the process and can be used for other purposes,” she explains.

The study’s biochemical analysis revealed that, even after removing the main active ingredients, the residual biomass retains properties that can be used in new products. “With the extract, we’re no longer serving just the brewing niche, but reaching five, six, or even ten different sectors,” Machado celebrates.

Top 5 VC Raises by Women-Founded Biopharmas

Venture capital flow to women-founded companies has stabilized in the post-pandemic environment. BioSpace looks back at five companies that have nabbed the most over the past two decades.
Biopharmas with women founders have contributed $64.1 billion in venture capital dollars across 3,375 deals since 2008, according to a recent analysis by PitchBook.

2025 has been a particularly good year for female-founded companies across all sectors, with $103.7 billion invested across 2,528 deals so far, according to PitchBook. Zeroing in on biopharma, the capital flow suggests that investment in female-founded companies is stabilizing in the post-pandemic environment. In 2025 so far, female-founded biopharmas have taken in $4.8 billion across 203 deals.

This is a significant drop from the peak in 2021, when $12.7 billion in venture capital was recorded for this category across 412 transactions. Since then, the numbers have declined as the sugar buzz wore off—a trend that is reflected across biopharma, regardless of the gender of the founders.

Much of the cash for women-founded biopharmas has centered in the U.S.’ two key biotech hubs: the Boston-Cambridge area, which saw $24.4 billion in investment across 759 total deals, and San Francisco-Oakland, where 618 deals netted $16.3 billion.

Investment rounds were split equally across early, late and angel rounds. Female-only founded companies took in $7.7 billion in 509 deals, compared to $56.4 billion over 2,866 deals for biopharmas co-founded by women and men.

The largest deal in the 16 years for which PitchBook has data was EQRx, which brought in $570 million in a series B in January 2021. The company, which has since gone out of business, had six founders including Melanie Nallicheri, Susan Hager and Sandra Horning.

Below, BioSpace looks back at the top five rounds since 2008 and where the companies are today.

EQRx

Deal Size: $570 million
Round: B
Founders: Alexis Borisy, Melanie Nallicheri, Robert Forrester, Susan Hager, Peter Bach and Sandra Horning

After a massive fundraising push over three years that raised a total of $1.97 billion, the ending for EQRx was not happy.

The company emerged with a big goal: to develop medicines that were not just innovative, but affordable. EQRx jumped to the markets quickly through a special purpose acquisition company (SPAC) in August 2021, picking up another $1.8 billion in proceeds.

But the lofty goal quickly met with clinical reality. The biotech’s antibody sugemalimab stumbled in the clinic, leaving executives reeling. EQRx pivoted to two other candidates, then ditched the low-cost goal. The staff was slashed in half, and EQRx later sold itself to Revolution Medicines in August 2023, preserving $1 billion in capital for that company. All of EQRx’s assets were terminated and returned to partners.

Neumora

Deal Size: $500 million
Round: A
Founders: Paul Berns, Kristina Burow, Robert Nelsen, Mike Poole, Morgan Sheng and Carol Suh

Believe it or not, a $500 million series A was not enough to earn Neumora the title of largest VC fundraise of 2021. Abogen’s whopping $700 million round nabbed that top slot. But that’s the nature of that year, when investors flocked to the sector buoyed by the hopeful innovation of COVID-19 vaccines that arrived at the end of 2020 to combat the pandemic.

Neumora was the fourth largest VC round of 2021—and that still made waves in the sector. The company emerged with the cash and a partnership with Amgen to develop therapies for neurodegenerative disorders. It has now raised a total of $987 million, including a $250 million IPO in September 2023, according to PitchBook data.

The path has not been a straight line for Neumore, however. In April 2024, the FDA slapped a clinical hold on the biotech’s schizophrenia asset as preclinical safety signals emerged.

But Neumora plowed on, unfortunately revealing a Phase III failure for the kappa opioid receptor (KOR) antagonist navacaprant in major depressive disorder in January this year. With two additional trials expected to readout for the drug this year, Neumora changed things up in March and pushed out the timeline to 2026.

After fielding all these challenges, Neumora is now on the cusp of releasing key Alzheimer’s disease data for NMRA-511. This could be the moment that $500 million seems worthwhile for investors.

Lyell Immunopharma

Deal Size: $493 million
Round: C
Founders: Rick Klausner, Crystal Mackall and Stan Riddell

Lyell Immunopharma was ahead of the pandemic-influenced biotech funding curve with a massive $493 million series C round in March 2020. Since then, the company has continued to battle in the tough cell therapy space, using its influx of cash from various fundraising mechanisms to bring in new approaches to address the modality’s limitations.

Founded by a team of cell therapy experts, Lyell has promised to develop next generation CAR T cell therapies for blood cancer and solid tumors by addressing T cell exhaustion and durability. Riding the wave of biotechs heading for the public markets in 2021, Lyell pulled off a massive $425 million IPO in June. Lyell’s GSK-partnered T cell receptor therapy hit the clinic the next year, but the success was short lived as the Big Pharma walked away from the $250 million three-year partnership months later.

Continuing on, Lyell reported mixed Phase I data for the CAR T therapy LYL797 in solid tumors in June 2024. The results revealed strong response rates across patients, but a death and high rates of cytokine release syndrome marred the readout. The asset was discontinued in October 2024, just as Lyell bought ImmPACT Bio for $30 million in cash plus shares.

The heart of that deal was an autologous dual-targeting CD19/CD20 CAR T, now known as rondecabtagene autoleucel (ronde-cel). Lyell began a pair of pivotal trials for the candidate this year, including a head-to-head test pitting ronde-cel against approved CD19 CAR T cell therapies, including Bristol Myers Squibb’s Breyanzi or Gilead’s Yescarta.

Lyell also followed the biopharma trend and picked up a new CAR T cell candidate from China’s Innovative Cellular Therapeutics.

Laronde

Deal Size: $440 million
Round: B
Founders: Avak Kahvejian, Noubar Afeyan, Nicholas Plugis, Erica Weinstein, Sophie Boer

This Flagship Pioneering–backed startup vowed to champion a new form of RNA medicines called Endless RNA upon launch in 2021. The company rode the success of Moderna—the star of Flagship’s portfolio—to a $440 million series B months after the public debut in July 2021.

But the journey was short lived. In June 2023, STAT published an expose on data integrity issues at the biotech. The company could not replicate the preclinical data that had underpinned the massive raise. Laronde cut two programs and many employees were forced to resign, including CEO Pablo Cagnoni.

Flagship folded the embattled biotech into another of its portfolio companies, Senda Biosciences, to form Sail Biomedicines in October 2023. That biotech is continuing the eRNA mission but has yet to enter the clinic.

BioNTech

Deal Size: $425 million
Round: N/A
Founders: Ugur Sahin, Özlem Türeci and Christoph Huber

BioNTech’s story has been told over and over—the Pfizer-partnered pandemic savior developed one of the two COVID-19 vaccines that helped bring the world back from the crisis. This generated billions in revenue and has helped fuel the biotech’s next phase.

But step back to January 2019, when the German mRNA company raised a remarkable $425 million, and you’ll see that BioNTech always had big ambitions. This later-stage round involved just two pharma entities: Pfizer Ventures with $333.5 million in cash and Sanofi with $91.5 million, according to Pitchbook data.

The company followed that year with a more traditional series B in July that totaled $325 million. These fundraises primed the biotech to enter the first year of the pandemic fully charged and ready for some R&D.

Lilly, Novo GLP-1 Pricing Plans Clear Runway For Future Competitors

While the TrumpRx deals only cover Lilly and Novo for now, the agreements are good for any cardiometabolic biotechs waiting in the wings, according to a new 2026 preview report from PitchBook.
New drug pricing plans for Novo Nordisk and Eli Lilly’s GLP-1 obesity treatments have cleared the runway for new entrants, with the regulatory bumps and grooves for insurance coverage smoothed out to open up a new patient population and bring in ever more investors, according to a new report from PitchBook.

In its annual exit report, the analysis firm said the addition of the approved GLP-1 drugs to Medicare and Medicaid with Most Favored Nation pricing expands the addressable market for the therapies by 7 to 15 million people. It also charts a new course for patients after they faced insurance denials for treatment.

While the TrumpRx deals only cover Lilly and Novo for now, the agreements are good for any biotechs waiting in the wings, PitchBook said.

“Expanded CMS coverage strengthens the case for broader GLP-1 label indications and reinforces long-term cardiometabolic franchise strategies,” the firm said. “Later entrants are positioned to benefit from a clearer regulatory pathway for obesity pharmacotherapy and a larger patient and prescriber base, which may accelerate adoption curves for differentiated products.”

With that said, PitchBook noted that Lilly and Novo are even more entrenched as the market incumbents with the deals in hand and manufacturing logistics already resolved. Any newcomers will still have to face those hurdles.

Nevertheless, the metabolic space will head into 2026 buoyed by exciting M&A developments, too. Specifically, the Pfizer-Novo bidding war to buy Metsera, which ultimately ended with Pfizer’s $10 billion takeover. While this week-long drama underscored the “escalating strategic urgency in this space,” PitchBook notes that there are 120 assets in development across 60 companies, and therefore plenty of potential deals to be made.

“As competition for late-stage assets intensifies, acquirers may move upstream, targeting earlier-stage, higher-risk platforms that offer novel biology or delivery modalities,” PitchBook wrote.

Appetite for Risk Rises

Overall, venture capital activity in biopharma bottomed out in the second quarter, but it seems to have returned in the third, PitchBook reported. This should continue into 2026, with additional rate cuts expected in the new year that could increase investors’ appetite for risk, the firm wrote.

Besides obesity, hungry Big Pharmas have been buying into CAR T cell therapy, antibody-drug conjugates and small molecules.

Thanks to the rise in larger deals—Cidara Therapeutics, Verona Pharma and Avidity Biosciences being recent examples—exit values have risen, even as deal counts remain muted. PitchBook named three companies with exit potential for 2026: the obesity-focused Verdiva Bio, Kailera Therapeutics and genetic medicine biotech ReCode Therapeutics.

On the policy front, PitchBook noted that the initial TrumpRx agreements have helped alleviate some concerns, but that 2026 will see the direct-to-consumer option open to patients for the first time.

“Despite headline price reductions, it remains uncertain whether the TrumpRx model will meaningfully lower patient out-of-pocket cost, although the benefit to pharma companies is clear as they avoid the potential for heavy import tariffs,” PitchBook said. “At a high level, the TrumpRx initiative underscores a growing push to bypass pharmacy benefit managers and improve price transparency.”

More accessible urban parks linked with greater physical activity across US cities

The health benefits of nature are well-known, but its role in encouraging day-to-day physical activity across different regions and demographics has been less clear. This question carries new urgency as the world faces a “physical inactivity pandemic,” with trends especially stark in the United States, where many people fall short of recommended activity levels.

To investigate how urban green spaces influence movement, researchers with the Stanford-based Natural Capital Project (NatCap), a global alliance focused on valuing nature’s benefits to people, analyzed wearable step-counter data in their new study published in Nature Health. They found that higher park accessibility, not simply more greenery, is associated with higher daily activity.

“Greenness alone doesn’t seem to encourage movement,” said Youngeng Lu, lead author of the paper, who did the work while he was a postdoctoral scholar at NatCap. “Even if you have lots of trees or vegetation, if you can’t easily reach them, it doesn’t translate to more physical activity. Accessibility to parks was the factor that mattered most.”

Measuring movement at scale

Past research links nature to physical activity, but many studies rely on self-reported data, focus on only a few cities, or track people for short periods. Those constraints limit how broadly the findings can be applied.

To take the next step in understanding these patterns, the team used multi-year wearable-device data from the All of Us Research Program, a national health initiative. Participants volunteered their Fitbit records, giving researchers three years of daily step counts and activity intensity from 7,013 anonymous users in 53 U.S. metropolitan areas. The team then used modeling that accounted for variations between individual people and cities to test how activity levels shifted with different types of urban nature.

The researchers distinguished between two aspects of urban nature: total greenness (measured from satellite imagery and including forests, gardens, and other vegetation) and park accessibility, which encompasses park existence, distance from population centers, and connectivity to one another. Using participants’ home locations, the team calculated how easy it is for residents to travel to nearby parks on foot.

Although overall greenness didn’t appear to be linked with higher physical activity, park accessibility was a strong predictor of movement. A 10% increase in park accessibility corresponded to roughly 107 additional steps per day.

Who benefits most?

The multi-year dataset allowed researchers to examine how the benefits of park access vary by region and demographic group over time. They also considered variables such as temperature, precipitation, population density, city walkability, and air quality, revealing some telling patterns in the game of step tracking.

Western and southern cities showed stronger links between park accessibility and movement, a trend the team suspects may be influenced by climate, culture, or outdoor habits. Lu emphasized the significant role temperature played in daily step counts. In mild climates, park accessibility had a much stronger effect on physical activity than in cities that are extremely hot or cold, where conditions are less favorable for outdoor exercise.

Demographic trends were also clear. Non-white residents, older adults, and people who were less active at baseline experienced the greatest increase in activity when parks were easier to reach. These results support the “equigenic effect,” in which improved access to green space disproportionately benefits more vulnerable communities.

“For non-white and lower-income neighborhoods, even small increases in park accessibility can encourage significantly more activity,” Lu said. “Parks need to be accessible to everyone, not just higher-income, white populations.”

Designing healthier cities

The study suggests that building new parks isn’t the only way for cities to increase the physical activity of their residents. Enhancing access to existing parks by improving walkability, removing barriers, and connecting parks to nearby neighborhoods (such as creating pedestrian overpasses) can also deliver public health benefits.

“It’s promising from a health perspective,” said Lisa Mandle, senior author on the paper, and director of science-software integration and lead scientist with NatCap. “Investing in access helps residents be more active and promotes equity in urban health.”

Lu added that the priority now is ensuring that the benefits of park access are shared equitably across cities. Future research could track changes in accessibility over time, incorporate GPS data to measure actual park use, and recruit more diverse participants to strengthen the evidence.

By continuing to explore nature’s role in public health, the team hopes to “inform urban planning decisions and inspire interventions that make cities healthier, greener, and more equitable for everyone,” Lu said.

“This study arose out of our efforts to understand how parks and nature in cities can benefit the people living there,” said Mandle. “We know green spaces provide mental health benefits, but we wanted to look more closely at physical activity, and specifically, who benefits most and in what contexts.”

This aligns with the broader goals of NatCap: “to advance understanding of the diversity of ways that nature benefits people in order to incorporate these values into decision-making,” Mandle said.

Electrotherapy using injectable nanoparticles offers hope for glioblastoma treatment

Electrotherapy using injectable nanoparticles delivered directly into the tumor could pave the way for new treatment options for glioblastoma, according to a new study from Lund University in Sweden.

Glioblastoma is the most common and most aggressive form of brain tumor among adults. Even with intensive treatment, the average survival period is 15 months. The tumor has a high genetic variation with multiple mutations, which often makes it resistant to radiation therapy, chemotherapy and many targeted drugs. The prognosis for glioblastoma has not improved over the past few decades despite extensive research.

How electrotherapy targets tumors

Electrotherapy offers another strategy to combat solid tumors. Using short, strong electric pulses (irreversible electroporation), non-reversible pores are created in the cancer cells leading to their death. The body’s immune system is simultaneously stimulated.

The problem is that surgery is required to place the stiff metal electrodes that are necessary for the treatment. In sensitive tissue, in the brain for example, this often entails a very difficult procedure, which has led to strict criteria regarding which patients can be treated.

Johan Bengzon is a researcher in glioblastoma and adjunct professor at Lund University, and consultant in neurosurgery at the Skåne University Hospital. He regularly treats patients with glioblastoma and is frustrated by the limited treatment options.

“The short distance between the hospital and the University in Lund facilitates cooperation and that’s why I contacted research colleagues to find out if injectable electrodes could be an alternative solution in electrotherapy,” says Johan Bengzon.

Injectable nanoparticles as a new approach

The research team, with Amit Singh Yadav, Martin Hjort, and Roger Olsson at the helm, had previously used nanoparticles to form injectable and electrically conductive hydrogels to control brain signaling and heart contractions. It is a minimally invasive method in which the particles are injected using a thin syringe directly into the body.

The particles break down after the treatment and thus do not need to be surgically removed. Perhaps the same technology could be used to destroy tumor cells in glioblastoma.

“After surgical treatment, unfortunately the glioblastoma tumor often returns on the outer edge of the area operated on. By drop casting the nanoparticles into the tumor cavity after an operation, we could electrify the edges while the immune system is also activated. In animal models, the procedure, due to this irreversible electroporation, led to tumors being wiped out within three days,” says Olsson, professor of chemical biology and drug development at Lund University, who led the study.

Early results and future prospects

The prospects are good and the researchers are very hopeful for the future, even though there is a long way to go before it becomes a clinical reality. The challenge is now to test the method on larger tumors.

“We have seen that the electrode is well received in the brain. We have not noted any problems relating to side effects and after 12 weeks the electrode disappeared by itself as it’s biodegradable. The technology combines direct tumor destruction with activation of the immune system and can be an important step towards more effective treatment of glioblastoma,” concludes Singh Yadav, researcher at Lund University and first author of the study.

Improved mapping system ends farm mislabeling, protecting coffee and cacao trade

A new system could overhaul maps that misclassify hundreds of thousands of smallholder coffee and cacao farmers as working in forests. Without better maps, deforestation regulations could ripple through markets from remote farms to a caffe mocha near you.

Sample Earth, launched by the Alliance of Bioversity International and CIAT and available on Harvard Dataverse, helps mapmakers build accurate, inclusive maps to prevent smallholder farmers from being wrongly classified as producing major commodities in forested areas. Misclassification risks excluding compliant producers from markets enforcing deforestation-free rules, particularly the European Union’s new regulation (EUDR).

The initiative is the result of a collaboration between Alliance researchers, tech companies (including Google), and the World Cocoa Foundation. Researchers call on private-sector mapmakers to adopt their model to harden their supply chains against disruption.

Producers of coffee and cacao, and the companies that buy their products, could soon lose access to the world’s second-largest economy. The European Union, at the end of next year, will phase in the long-delayed EUDR legislation that requires many agricultural commodities to be certified deforestation-free. Unfortunately, hundreds of thousands of producers will face considerable hurdles, and not because they produce on land that hasn’t been deforested since 2020 (the EU’s cutoff date): It’s due to maps that wrongly classify their farmland as forest.

For example, the EU’s main reference map, published in 2025, misclassifies more than half the coffee production zones in Colombia, China, Guatemala and Mexico as forest, according to research by the Alliance of Bioversity International and CIAT. Similar reference maps have the same shortcomings. This is because these maps are “trained” on land-cover datasets that largely exclude remote areas cultivated by smallholders.

Improving these maps is urgent. To spark the creation of better maps, the Alliance recently launched Sample Earth, a trusted and inclusive global benchmark and reference dataset that accurately represents remote smallholder farms. The initial data tranche includes approximately 100,000 open-access, time-stamped geolocation points in Ghana and Vietnam. The countries are the second-largest producers of cacao and coffee, respectively.

“Maps are needed for due diligence, and buyers will likely steer clear of areas misclassified as ‘high risk’ for deforestation,” said Louis Reymondin, a data scientist at the Alliance. “With Sample Earth, we invite governments, companies, NGOs and research institutions to invest in expanding this inclusive, high-quality land-cover reference to preserve livelihoods and incentivize environmental protection.”

Smallholders produce an estimated 60% of the world’s coffee and 90% of its cacao. If maps used for compliance are inaccurate, buyers may decline purchases from entire regions rather than risk penalties for non-compliance, effectively shutting smallholders out of major markets.

“Most maps are not accurate at local scales because the data is biased toward regions with a lot of training data,” said Thibaud Vantalon, a scientist at the Alliance’s Digital Inclusion research area. “Remote regions are very poorly mapped. Sample Earth means to fill this gap in training data for smallholders.”

Making map-making better

Sample Earth is designed to improve map accuracy and to streamline the map-making workflow. Data scientists, the people who make maps with satellite imagery, spend an estimated 80% of their time collecting, cleaning and organizing training data. Sample Earth provides reference samples to reduce that burden and speed up the creation of accurate land-cover maps for compliance.

“High-quality data and data-based action are the foundation for compliance with deforestation-free rules and net-zero carbon emission targets,” said Michael Matarasso, the Impact Director and Head of North America at the World Cocoa Foundation (WCF), a partner in Sample Earth.

“However, highly accurate public data is rare… This poses a significant risk to all stakeholders involved. A standard to deliver highly accurate and transparent data in partnership with governments and farmers is of critical importance more than ever.”

Sample Earth aims to set a new transparency and quality benchmark for map-based compliance tools. Currently, no universal standard exists for third-party accuracy assessments of maps used in deforestation due diligence. Sample Earth plans to include a built-in improvement mechanism that allows mapmakers to access confidential land-use reference data to validate and refine their maps without exposing individual farmers’ locations.

“Global forest maps have advanced, but without open, standardized reference data, progress in disambiguating forest land use from other land use like cacao and coffee agroforestry remains limited” said Rémi d’Annunzio, Forestry Officer at FAO and product manager of Whisp. “Today, initiatives like the Forest Data Partnership and DIASCA are putting efforts such as Sample Earth high on the global agenda as we work to define and standardize guidelines for open reference data collection.”

Sample Earth builds on nearly two decades of Alliance research using satellite imagery to monitor land-cover changes across the Global South. The team plans to expand the dataset within Vietnam and Ghana and add other countries with high rates of misclassified smallholder farms, including Colombia and Honduras, along with coffee- and cacao-producing nations across Africa and Asia.

Seeking modern cartographers

Sample Earth’s roster of collaborators includes the United Nations’ Food and Agriculture Organization, Germany’s international development agency (GIZ), Google, Satelligence and WCF. The Alliance is actively seeking more collaborators and investors.

“For EUDR to succeed, we need to lower the burden of monitoring and reporting, and we need to ensure that longstanding smallholder farms can be reliably reported as non-deforested areas,” said Dan Morris, a researcher at Google AI for Nature and Society. “AI combined with satellite imagery is a powerful tool that can help address these challenges, but AI systems are only as good as their training and validation data.”

Inaction could disrupt supply chains and consumer markets, and not just in the EU; other jurisdictions are following suit in building similar legislation that will apply to most agricultural commodities. Supply constraints are feasible if maps do not quickly improve, which could push up prices. It’s bad news across supply chains, from vulnerable smallholders who already face myriad challenges to food-inflation-weary consumers worldwide.

Sample Earth’s proposition is straightforward: better, inclusive training datasets will yield more accurate maps, protect compliant farmers from unwarranted exclusion, and give buyers and governments transparent tools to verify deforestation-free claims. By filling the data gaps that leave smallholder landscapes underrepresented, Sample Earth aims to make compliance affordable and fair, while supporting conservation and sustainable livelihoods in the tropics.

Provided by The Alliance of Bioversity International and the International Center for Tropical Agriculture

A farmer’s field of dreams? Smart tech maps moisture levels, will adjust watering automatically

A wheat field near Elberta, Utah, just became the most technically sophisticated wheat field on Earth, thanks to a talented team of BYU professors and students.

The team of engineers placed 86 Bluetooth devices throughout the 50-hectare (124-acre) field to measure water levels across every inch of the field. Placing this many sensors in a commercial field is unprecedented and allows researchers to see unique patterns that have never before been captured.

Each of these sensors, called BYU Smart Bluetooth Stakes, is powered by a credit-card-sized solar panel and uses two metal prongs to gauge the soil moisture as often as every minute. The system is significantly more accurate than traditional water saturation measurement methods and provides a map of where water is needed.

“We took existing technology—they’re the same kind of microchips that would be inside your Bluetooth headphones—and we put them on a platform, added solar powering, probes to measure soil moisture, and then just made the whole package waterproof and outdoor-capable so that it could be left for a long period of time,” said Ph.D. student and team member Samuel Craven. “They have to be really small, low enough to the ground that a farmer’s tractor can go over top of it, and cheap enough that we can do hundreds of them.”

The project is part of Craven’s dissertation and was published in the journal Sensors.

The smart Bluetooth stakes are placed prongs-down in the ground and work together with a smart receiver attached to a center pivot sprinkler system. An important finding from their research showed that switching to a parabolic antenna for the smart receiver significantly improved signal strength and range. The receiver was able to collect data more reliably across the field, especially from distant stakes, with a range increase from 300 meters to 600 meters.

Getting to that point required extensive research and experimentation. BYU electrical and computer engineering professor Brian Mazzeo pulled together an interdisciplinary research team of students and faculty—including plant and wildlife sciences professor Neil Hansen and geography professor Ruth Kerry—to take it on.

“We decided to go with Bluetooth because it’s inexpensive, it’s readily available, the wavelengths, everything. There are a lot of things that made it very attractive, but the research itself, goes beyond that,” Mazzeo said. “Somebody may come up with a better wireless solution, and that’s okay, but understanding the density of sensors necessary is a critical question that farmers and other agricultural professionals need to know.”

Working through a drought is an expected challenge for farming in the West, including the desert lands of Utah. The BYU Smart Bluetooth Stakes provide a way to deliberately use water resources in the ways farmers need them and better navigate drought conditions while still maintaining healthy crop production.

“We’re solving real, practical problems,” Kerry said. “It’s very heartening to realize we can solve these problems if we work together.”